Literature DB >> 17289227

Avian and pandemic influenza: an overview.

Gregory A Poland1, Robert M Jacobson, Paul V Targonski.   

Abstract

Influenza A/H5N1 (avian influenza) has now caused 258 human infections (as of November 13, 2006), with an approximate 50% mortality rate. Because the virus is novel in terms of antigenic type and causes infection and illness, and because humans have no pre-existing immunity, the conditions for a possible pandemic exist. Additionally, wild migratory birds appear to be spreading the virus across ever larger geographic areas, and newer clade 2 influenza A/H5N1 viruses have begun to emerge. The US Congressional Budget Office has formally modeled the likely consequences of pandemic influenza and estimates that up to 2 million of the US population might die, with up to 40% of all workers ill for as long as 3 or more weeks. This brief overview will review basic virologic, immunologic and epidemiologic information relevant to understanding and preparing for this threat. In particular, the role of avian influenza vaccines will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289227     DOI: 10.1016/j.vaccine.2007.01.050

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.

Authors:  M A Hoelscher; L Jayashankar; S Garg; V Veguilla; X Lu; N Singh; J M Katz; S K Mittal; S Sambhara
Journal:  Clin Pharmacol Ther       Date:  2007-10-24       Impact factor: 6.875

2.  Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.

Authors:  Frédéric Kendirgi; Nadezda E Yun; Nathaniel S Linde; Michele A Zacks; Jeanon N Smith; Jennifer K Smith; Harilyn McMicken; Yin Chen; Slobodan Paessler
Journal:  Hum Vaccin       Date:  2008-11-21

3.  Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.

Authors:  Sean A Gray; Margaret Moore; Emily J VandenEkart; Richard P Roque; Richard A Bowen; Neal Van Hoeven; Steven R Wiley; Christopher H Clegg
Journal:  Antiviral Res       Date:  2016-04-21       Impact factor: 5.970

Review 4.  Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Authors:  Monique P Curran; Isabel Leroux-Roels
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

Review 5.  Clinical vaccine development for H5N1 influenza.

Authors:  Christopher H Clegg; Joseph A Rininger; Susan L Baldwin
Journal:  Expert Rev Vaccines       Date:  2013-07       Impact factor: 5.217

6.  Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.

Authors:  Daniel Dlugolenski; Les Jones; Elizabeth Howerth; David Wentworth; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

7.  Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

Authors:  Bao-Zhong Wang; Rui Xu; Fu-Shi Quan; Sang-Moo Kang; Li Wang; Richard W Compans
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).

Authors:  Nadezhda E Yun; Nathaniel S Linde; Michele A Zacks; Ian G Barr; Aeron C Hurt; Jeanon N Smith; Natallia Dziuba; Michael R Holbrook; Lifang Zhang; John M Kilpatrick; C Shane Arnold; Slobodan Paessler
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

9.  Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

Authors:  Langzhou Song; Yi Zhang; Nadezhda E Yun; Allison L Poussard; Jeanon N Smith; Jennifer K Smith; Viktoriya Borisevich; Jenna J Linde; Michele A Zacks; Hong Li; Uma Kavita; Lucia Reiserova; Xiangyu Liu; Kunmi Dumuren; Bhuvaneswari Balasubramanian; Bruce Weaver; Jason Parent; Scott Umlauf; Ge Liu; Jim Huleatt; Lynda Tussey; Slobodan Paessler
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

10.  H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation.

Authors:  Guihua Wang; Dawei Zhan; Laixing Li; Fumin Lei; Bohua Liu; Di Liu; Haixia Xiao; Youjun Feng; Jing Li; Baoan Yang; Zuohua Yin; Xiaohui Song; Xiaojia Zhu; Yanlong Cong; Juan Pu; Jian Wang; Jinhua Liu; George F Gao; Qingyu Zhu
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.